Watson appoints former GPhA executive as VP government affairs
PARSIPPANY, N.J. — Generic drug maker Watson Pharmaceuticals has hired a former executive from the Generic Pharmaceutical Association to head lobbying at the federal and state level, the company said Wednesday.
Watson announced the appointment of James Fenton as VP U.S. government affairs. In the new position, Fenton will work out of Watson’s Washington offices and will be responsible for leading the company’s expanded federal and state government affairs activities.
Fenton previously served as the GPhA’s SVP government affairs, directing the industry group’s government affairs efforts and playing a role in the passage of the Generic Drug User Fee Act. Before working for GPhA, Fenton worked for 15 years in the office of former Democratic Sen. Christopher Dodd of Connecticut, most recently as chief of staff.
Mobile app increased medication adherence to 81%, developer says
HAIFA, Israel — The makers of a new app say that it increased users’ medication adherence rate to more than 80%.
The MediSafe Project said Tuesday that users reported medication adherence rates of 81%, while the rate was 84.25% for patients using statins.
According to post-launch data collected over eight weeks, users of the MediSafe Project recorded taking their drugs on time at a rate 31% higher than the World Health Organization’s estimated average adherence rate of 50%. The app, launched in November 2012, is described as the first "pillbox app" that cloud syncs users’ failure to take medication on time to their friends, family and caregivers.
"Medication adherence is a persistent and elusive problem, interrupting patients’ well-being, costing health providers and insurers billions annually and causing preventable deaths," MediSafe Project CEO Omri Shor said. "MediSafe Project’s involvement of patients’ loved ones and caretakers is providing itself a breakthrough in reducing the harm that comes from medication nonadherence."
Campaign seeks to raise awareness of inflammatory bowel disease
NEW YORK — An organization focused on inflammatory bowel disease has enlisted a star of "NYPD Blue," "Judging Amy" and "Private Practice" to raise awareness of the condition.
The Crohn’s and Colitis Foundation of America hired actress Amy Brenneman, who has ulcerative colitis, one of two diseases that collectively make up IBD; the other is Crohn’s disease. Both conditions are autoimmune diseases that cause discomfort and inflammation of the intestines and require frequent trips to the bathroom.
The CCFA also launched an ad campaign, Escape the Stall, which includes ads showing various people in restroom stalls in order to raise awareness that IBD can affect anyone.